Get started
AdvisorShares Psychedelics ETFAdvisorShares Psychedelics ETFAdvisorShares Psychedelics ETF

AdvisorShares Psychedelics ETF

No trades
See on Supercharts
Overview Analysis
Holdings
News Ideas Discussions Technicals Seasonals Options

AdvisorShares Psychedelics ETF holdings


As of July 16, 2025
Symbol
Weight %
Shares
Market value
A
ATAIATAI Life Sciences N.V.
9.25%
‪‪389.76 K‬‬
‪‪1.05 M‬‬USD
M
MNMDMind Medicine (MindMed), Inc.
8.26%
‪‪109.59 K‬‬
‪‪940.31 K‬‬USD
Q
QNTMQuantum Biopharma Ltd. Subordinate Voting Shares Class B
7.30%
‪‪36.99 K‬‬
‪‪830.80 K‬‬USD
C
CYBNCybin, Inc.
7.03%
‪‪106.38 K‬‬
‪‪800.00 K‬‬USD
N
NRXPNRX Pharmaceuticals, Inc.
6.98%
‪‪263.80 K‬‬
‪‪794.03 K‬‬USD
S
SAGESAGE Therapeutics, Inc.
6.71%
‪‪83.64 K‬‬
‪‪763.65 K‬‬USD
A
ALKSAlkermes Public Limited Company
6.69%
‪‪26.07 K‬‬
‪‪761.39 K‬‬USD
C
CMPSCOMPASS Pathways Plc Sponsored ADR
6.65%
‪‪192.54 K‬‬
‪‪756.69 K‬‬USD
G
GHRSGH Research Plc
6.50%
‪‪42.76 K‬‬
‪‪739.25 K‬‬USD
N
NBIXNeurocrine Biosciences, Inc.
5.47%
‪‪4.67 K‬‬
‪‪622.82 K‬‬USD
Get deeper insights with ETF data
Explore detailed ETF holdings data, including weight, shares, and market value.